Navigation Links
ULURU Inc. Reports Third Quarter 2010 Financial Results
Date:11/15/2010

61,617130,234528,481435,057COSTS AND EXPENSESCost of goods sold

6,4167,785143,25922,783Research and development

295,781376,191948,9602,006,070Selling, general and administrative

666,205981,2122,405,1235,041,318Amortization of intangible assets

206,454272,102699,252807,551Depreciation

79,07346,424179,053126,002Total Costs and Expenses

1,253,9291,683,7144,375,6478,003,724OPERATING (LOSS)( 1,192,312)( 1,553,480)(3,847,166)(7,568,667)Other Income (Expense)Interest and miscellaneous income

4,8406,6765,55542,296Interest expense

(20,650)(1,926)(37,138)(1,926)Loss on sale of intangible asset

------( 857,839)---Loss on sale of equipment

---------(2,121)(LOSS) BEFORE INCOME TAXES(1,208,122)( 1,548,730)(4,736,588)(7,530,418)Income taxes

------------NET (LOSS)$(1,208,122)$(1,548,730)$ (4,736,588)$ (7,530,418)Basic and diluted net (loss) per common share

$   (0.01)$   (0.02)$  (0.06)$  (0.11)WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

82,084,31666,038,07981,346,13865,723,998ULURU Inc. SELECTED CONDENSED CONSOLIDATED BALANCE SHEET DATASeptember 30, 2010December 31, 2009(Unaudited)(Audited)  Cash and cash equivalents

$
,320,021$
,934,177  Current assets

2,904,0613,544,850  Property and equipment, net

1,452,5041,631,557  Other assets

5,853,4168,203,965  Total assets

10,209,98113,380,372  Current liabilities

1,149,342929,771  Long term liabilities – deferred revenue

1,461,9021,272,843  Total liabilities

2,611,2442,202,614  Total stockholders' equity

7,598,73711,177,758
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Spherix Reports Second Quarter Earnings
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013  Sanofi (EURONEXT: SAN and NYSE: ... JAKARTA , examining the selective JAK2 inhibitor ... both dose groups. The primary endpoint assessed the proportion ... with data reported in previous trials, the most common ... results will be presented at an upcoming medical congress. ...
(Date:5/17/2013)... -- Sinovac Biotech Ltd. (Nasdaq: SVA ), a ... today announced that it will release its unaudited financial results ... on Tuesday, May 28, 2013.  The Company will host a ... EDT (May 28, 2013 at 8:00 p.m. China Standard Time) ... on recent corporate developments. To access the conference ...
(Date:5/16/2013)... and ZURICH , May 17, 2013 /PRNewswire/ ... Science, Technology and Research (A*STAR) and Switzerland,s ... volunteer has been dosed in a Phase 1 clinical trial ... bacteriophage Qbeta virus-like particle (VLP) technology. In this first Phase ... vaccine candidate and its potential to protect against H1N1 influenza ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6
(Date:5/19/2013)... 2013 Healthcare leaders will gather at ... the Walt Disney World Swan and Dolphin in Orlando, ... innovation, care delivery and healthcare reform and implementation. , ... healthcare markets, with consolidation, efficiency and reduced ... Todd Ebert, Amerinet president and CEO. “There is a ...
(Date:5/19/2013)... The muscles in the human body are dependent ... the biggest and most significant nervous systems in the ... comprises of peripheral nerves that reside outside of the ... the limbs and hands, as well as other organs, ... due to trauma or physical injury, their functionality is ...
(Date:5/19/2013)... These molecular diagnostics market reports ... Japan, Italy, Germany and France:, ... practice, as well as key economic, regulatory, demographic, ... during the next five years. ,     An ... test formats, detection methodologies, trends in testing automation ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Farming methods ... seed in the ground 10,000 years ago. Most recently, ... farm productivity by using genetically engineered seeds and by ... seeing a backlash to these techniques due to the ... chemicals and a corresponding surge in interest in organic, ...
(Date:5/19/2013)... Agora Health Limited developed by Rachael Linkie is ... how to increase memory power naturally and effectively. The ... people re-new their entire health from the inside out. It ... a fatigued mind. In addition, the program helps people keep ... The author claimed that this program can help people overcome ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders Gather at 2013 Amerinet Member Conference to Share New Ways to Reduce Costs and Enhance Care Delivery 2Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2
... Beauty Professionals Encouraged to Share Educational Materials , ... , WASHINGTON, July 23 Look ... to help women cope with the appearance-related changes of cancer treatment, today ... to generate awareness and increase program participation during its 20th anniversary year. ...
... , , Infusion ... LOUISVILLE, Ky., July 23 University of Louisville physicians performed the ... Louisville, KY, on July 17, 2009. The procedure is part of the ... disease. , , The first ...
... , SAN DIEGO, July 23 Orexigen Therapeutics, ... has priced an underwritten public offering of 10,000,000 shares of ... Net proceeds, after estimated underwriting discounts and commissions and estimated ... underwriter a 30-day option to purchase up to an additional ...
... July 23 Estimates place the prevalence of physical disabilities ... the global adult population according to THE ORTHOPAEDIC INDUSTRY ... , "Our sources indicate that ... 25 percent over the past ten years, and those conditions ...
... /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH.PK) ( http://www.mitcanada.ca ... that it has been granted a completely new, 8,000 ... from the "China Medical City" in Taizhou city for ... operation facility will harbor all the sub-assembly, final assembly ...
... , , , ... TELEHOUSE America ( www.telehouse.com ... Internet exchanges, and managed IT services, today announced it is offering ... loss prevention (DLP) consulting services as part of its ...
Cached Medicine News:Health News:Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month 2Health News:Look Good...Feel Better Launches Salon Awareness Campaign During National Breast Cancer Awareness Month 3Health News:Orexigen(R) Therapeutics Prices Public Offering of Common Stock 2Health News:THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT Highlights the Burgeoning Demographics of Orthopaedics and the Continuing Health of the Industry 2Health News:MIT granted an 8,000 square foot operation facility in Taizhou city for a period of 2 and half years 2Health News:TELEHOUSE America Offers Integralis' Data Loss Prevention Consulting Services as Part of its Manage-E Solution 2Health News:TELEHOUSE America Offers Integralis' Data Loss Prevention Consulting Services as Part of its Manage-E Solution 3Health News:TELEHOUSE America Offers Integralis' Data Loss Prevention Consulting Services as Part of its Manage-E Solution 4
... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
Medicine Products: